The fentanyl crisis continues to be a pressing issue in the United States, prompting various legislative measures and trade policies. Recent actions include the imposition of tariffs by President Trump aimed at addressing the supply chain of synthetic opioids from China. However, critics argue that these tariffs may not effectively solve the crisis, suggesting that the opioid epidemic requires more comprehensive strategies. Senators such as Nunn and Barr are leading bills to hold Chinese fentanyl producers accountable, while debates arise over the legality and effectiveness of these tariffs in relation to international trade rules. As the situation evolves, many maintain that unilateral trade actions alone cannot resolve the systemic challenges posed by fentanyl and other illicit drugs.